The Neutrophil-to-Monocyte Ratio and Platelet-to-White Blood Cell Ratio Represent Novel Prognostic Markers in Patients with Pancreatic Cancer

Table 5

Comparison of median survival time and 95% CI at different levels of variables.

Variables	Median survival time and 95% CI (month)
	Low-level group (0 or 1)	High-level group (1 or 2)
Age (<65/≥65)	2.0 (1.5-2.5)	2.0 (1.7-2.3)	105/164	0.988	0.320
Gender (M/F)	2.0 (1.6-2.4)	2.0 (1.6-2.4)	155/114	0.089	0.765
TNM stages	4.0 (3.2-4.8)	2.0 (1.7-2.2)	45/224	16.435	<0.001
CA199	3.0 (2.1-3.9)	2.0 (1.7-2.3)	30/204	4.510	0.034
NMR	4.0 (3.5-4.5)	1.0 (0.95-1.05)	124/145	266.357	<0.001
PWR	4.0 (3.5~4.5)	1.0 (0.95-1.05)	125/144	265.941	<0.001